AC Transit Logo
Share to Facebook Share to Twitter Bookmark and Share
Report ID: 21-031   
Type: Regular - Operations
Meeting Body: Board of Directors - Regular Meeting
Meeting Date: 1/13/2021 Final action: 1/13/2021
Recommended Action: Consider receiving a preliminary report on the development of AC Transit's Vaccination Plan for COVID-19 vaccinations.
Attachments: 1. STAFF REPORT, 2. Att.1.COVID-19 vaccine — what employers need to know _ Kaiser Permanente, 3. Att.2. COVID-19 Vaccination Plan - Alameda County, 4. Master Minute Order
TO: AC Transit Board of Directors
FROM: Jill A. Sprague, General Counsel
Michael A. Hursh, General Manager
SUBJECT: AC Transit Vaccination Plan

BRIEFING ITEM

RECOMMENDED ACTION(S):

Title
Consider receiving a preliminary report on the development of AC Transit's Vaccination Plan for COVID-19 vaccinations.
Body

STRATEGIC IMPORTANCE:

Goal - Safe and Secure Operations

With the Food and Drug Administration's (FDA) emergency use authorization for two COVID-19 vaccines, and the Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices' (ACIP) identification of public transit workers as a high priority group to be included in Phase 1b of vaccine prioritization, it is imperative that the District have a plan for the implementation and administration of vaccines to its employees.

BUDGETARY/FISCAL IMPACT:

The fiscal impact of a Vaccination Plan is currently unknown, but may include costs associated with administering vaccinations, education and communication campaigns, and pay associated with "on the clock" vaccinations.

BACKGROUND/RATIONALE:

After many long months of the COVID-19 pandemic, there are now two COVID-19 vaccines approved by the FDA for emergency use. The vaccines will be a vital tool for controlling and eventually ending this pandemic that has caused so much loss, pain, and disruption. This next essential step in the fight against COVID-19 will take time - but things are moving in the right direction.

Vaccine distribution has been separated into phases, based on ACIP's identification of high-risk, high priority groups, who will receive vaccines first:
* Phase 1a - approximately 24 million people1:
o Health care workers - because of their higher risk for exposure, and to help prevent them from transmitting COVID-19 to patients
o Residents of long-term care facilities - because they represent 40% of COVID-19 deaths
* Phase 1b - approximately 51 million people:
o People age 75 years and older
o Essen...

Click here for full text